Furthermore, advanced stages of NAFLD have been associated with a global hypomethylation and concomitant over-activation of a pro-fibrogenic gene program, as exemplified at fibroblast growth factor receptor 2 (FGFR2) [96]. This evidence concerns the gene FGFR2 and metabolic dysfunction-associated steatotic liver disease.